Skip to content
The Quiet LedgerBeyond the noise. On the record.
FEC candidate · S8DE00079

CARPER, THOMAS R.

Senate · DE · DEMLinked to member C000174 (deterministic · office+state+exact-normalized-name (unique))Sign in to watch / set alerts
Reported financial totals by cyclesource: FEC candidate summary
CycleReceiptsDisbursementsIndividual contributionsCash on hand (end)DebtsCoverage through
2024$232,443$731,738$133,593$55,790$02024-12-31
2022$883,553$632,816$330,435$555,085$02022-12-31
2020$688,511$744,805$274,166$304,348$02020-12-31
2018$3,236,955$3,121,074$1,260,577$360,642$02018-12-31
2016$627,565$760,838$158,291$244,760$02016-12-31
Totals are the FEC's reconciled candidate summary for each two-year cycle — not a sum of itemized rows. A cycle is the election period, distinct from a congressional term.
Receipts by cycle (factual)
2016$627,565
2018$3,236,955
2020$688,511
2022$883,553
2024$232,443
FEC reconciled receipts per cycle. A factual time series — not a score, ranking, or partisan measure.
Authorized & associated committees2
CommitteeDesignation (as reported)TypeParty
HEINRICH CARPER VICTORY FUNDJoint fundraisingS
CARPER FOR SENATEPrincipal campaign committeeSDEM
Committee associations are the FEC's own candidate-committee linkage. A committee referencing a candidate is not necessarily controlled by the candidate.
Independent expendituresreported · not contributions to the candidate
SpenderPosition (as reported)AmountDate
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose-$33,8462019-05-03
PATRIOT MAJORITY PACSupport$105,5002018-10-26
PATRIOT MAJORITY PACSupport$105,5002018-10-26
PLANNED PARENTHOOD VOTESSupport$362018-10-25
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-24
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-24
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-24
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-24
PATRIOT MAJORITY PACSupport$100,0002018-10-19
PATRIOT MAJORITY PACSupport$100,0002018-10-19
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-17
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$46,9102018-10-17
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$46,9102018-10-17
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-17
PLANNED PARENTHOOD VOTESSupport$362018-10-08
SIERRA CLUB INDEPENDENT ACTIONSupport$102018-10-08
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-03
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-10-03
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-09-28
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-09-28
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$25,0002018-09-27
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$25,0002018-09-27
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$27,2462018-09-14
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$24,2482018-09-14
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$300,0002018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$300,0002018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONSupport$559,9502018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$47,4802018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$47,4802018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$300,0002018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$47,4802018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$559,9502018-09-13
PATIENTS FOR AFFORDABLE DRUGS ACTIONOppose$300,0002018-09-13
NEA ADVOCACY FUNDSupport$682018-08-16
DELAWARE STATE AFL-CIOSupport$90,0002012-10-31
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
RENEW DELAWARE PACOppose$2,2912012-10-16
An independent expenditure is spending by a committee that is not coordinated with the candidate; the support/oppose position is reported by the spender. It is not a contribution to the candidate and does not imply candidate involvement.

All figures are as reported to the FEC. This page presents documented campaign-finance facts; it assigns no score, ranking, or influence judgement to the candidate or the linked member.